The main targets of Ginkgo biloba leaves in the treatment of NSCLC were TP53, AKT1, TNF, IL-6, and CCND1, we conclude that Ginkgo biloba leaves may act through PI3K-AKT and MAPK signaling pathways. Here, CCND1 is linked to non-small cell lung carcinoma.